The Impact of PRAME Expression on Breslow Depth in Melanoma Arising in Dysplastic Nevi in a Large Multi-State Dermatology Group

Journal Title: Journal of Dermatology Research - Year 2024, Vol 5, Issue 2

Abstract

Background: PRAME immunohistochemistry has been reported to be positive in at least 83.2% of invasive melanomas while being positive in no more than 13.6% of benign nevi. Melanoma may arise within pre-existing nevi or dysplastic nevi and PRAME could potentially have an effect on the measured Breslow depth. Objective: We performed a retrospective review of invasive melanoma cases diagnosed over a 4 year period to evaluate if the use of PRAME had an impact on Breslow depth. Methods: Diagnostic reports were reviewed to separate out cases of invasive melanoma that arose in precursor nevi or dysplastic nevi. The final sample size is 152 cases. Results: The average melanoma depth in the PRAME group was 0.51 mm, while being 0.68 mm in the no PRAME group (p<0.05). The pathologic stage was unchanged in all cases. Limitations: The pathology reports were made by multiple dermatopathologists and therefore reporting of precursor nevi on the reports may not be entirely uniform. Conclusion: PRAME does impact the Breslow depth of invasive melanoma when arising in precursor nevi, but significant alterations in the pathologic stage were not observed.

Authors and Affiliations

Brevin McCool, Antonio Ray, Michael Hatch, Cary Chisholm

Keywords

Related Articles

Oral Clarithromycin Therapy for Perioral Dermatitis in Children: A Retrospective Case-series Study

Background: Effective treatments for pediatric periorificial dermatitis are limited. We assessed the clinical utility of oral Clarithromycin (CLR) in pediatric patients with periorificial dermatitis. Methods and Findi...

Interleukin-36 and Generalized Pustular Psoriasis: A Narrative Review of the Role of IL-36 in Generalized Pustular Psoriasis and an Update on Treatments

Generalized Pustular Psoriasis (GPP) is one of the rare variants of Psoriasis vulgaris. It can be life-threatening, especially in pregnant women or in a setting of multiple co-morbidities. The pathophysiology of chronic...

Epithelioid Hemangioma: Report of a Case Series of 4 Patients

Epithelioid hemangioma or Angiolymphoid Hyperplasia with Eosinophilia (ALHE) is a rare benign vascular disease, characterized by solitary or multiple angiomatous papules and nodules, which are usually located on the skin...

The Efficacy and Safety of Oral Propranolol in Hemangioma of PHACES Syndrome: A Case Report

PHACES syndrome is a rare condition characterized by the association of infantile hemangioma with malformations of the posterior fossa of the brain, arterial anomalies of the central nervous system, heart defects, ocular...

Perspectives on the FDA’s Sunscreen Policy: New Aging Theory, Sunlight Benefits, Enhanced Immunity, COVID-19 Mortality, Modelling Analyses, Melanoma Risks and Etiology

Currently, the U.S. Food and Drug Administration’s policy on sunscreens assumes that exposure to sunlight, mainly ultraviolet (UV) rays, damages the skin, the damage is cumulative and any sun exposure should be avoided...

Download PDF file
  • EP ID EP741619
  • DOI https://doi.org/10.46889/JDR.2024.5207
  • Views 17
  • Downloads 0

How To Cite

Brevin McCool, Antonio Ray, Michael Hatch, Cary Chisholm (2024). The Impact of PRAME Expression on Breslow Depth in Melanoma Arising in Dysplastic Nevi in a Large Multi-State Dermatology Group. Journal of Dermatology Research, 5(2), -. https://europub.co.uk/articles/-A-741619